Topic: 
Update On Subject Matter Eligibility in the Life Sciences
Speaker: Courtenay Brinckerhoff, Partner, Foley and Lardner LLP
Date: Thursday, March 24, 6:00 pm
Location: San Diego Marriott Del Mar, 11966 El Camino Real, San Diego

Please join us for a presentation on current subject matter eligibility jurisprudence in the life science space. Ms. Brinckerhoff, who edits and is the primary author of PharmaPatentsBlog.com, will discuss current USPTO guidance and implementation, recent and upcoming court decisions, and possible legislative “fixes.”

About Courtenay Brinckerhoff

Courtenay Brinckerhoff is a partner with Foley & Lardner LLP. She is chair of the firm’s IP Law and Practice Committee, past vice chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice, and editor of PharmaPatentsBlog.com.

Ms. Brinckerhoff’s practice focuses on client counseling in all aspects of obtaining, licensing and enforcing patents, conducting freedom-to-operate and due diligence investigations, and representing Patent Owners and Petitioners in Patent Office trial proceedings. Over the past 20 years, she has represented clients before the U.S. Patent Office, the U.S. Patent Trial and Appeal Board, and the U.S. Court of Appeals for the Federal Circuit.

Ms. Brinckerhoff works with clients in diverse industries, including pharmaceuticals (chemical and biotechnological), human and animal food products, nutraceuticals, and medical devices. She has particular experience with transdermal pharmaceutical products (patches, gels and liquids), oral dosage forms (including controlled release and extended release formulations), enzyme-based technologies, diagnostic and therapeutic antibodies, active and passive immunization therapies, and personalized medicine.

Ms. Brinckerhoff joined Foley as an associate in the fall of 2001, after clerking for the Honorable Judge Schall on the U.S. Court of Appeals for the Federal Circuit. Prior to her clerkship, she worked at Foley as a patent agent and law clerk.

Ms. Brinckerhoff graduated from George Mason University School of Law (J.D., summa cum laude, 1999) as valedictorian of her class. While a law student, she served as a member of the George Mason University Law Review and published an article in the University of Baltimore Intellectual Property Law Journal related to legislation that limits liability for infringement of medical method patents.

Ms. Brinckerhoff graduated from the University of Virginia with a B.S. in chemistry, with distinction, in 1988 and was elected to Phi Beta Kappa. In 1988, Ms. Brinckerhoff received an award for outstanding achievement in chemistry from the Virginia Section of the American Chemical Society.